Introgen Therapeutics, Inc. (INGN)

Article Abstract:

The operations and management of Intogen Therapeutics Inc of Austin, TX, are discussed in detail by president and CEO David G. Nance. Gene therapy products for cancer treatment is the company's major focus.

User Contributions:

Comment about this article or add new information about this topic:

Comment:  (50-4000 characters)

Name:

E-mail:

Security Code:

Ortec International, Inc. (ORTC)

Article Abstract:

The operations and management of Ortec International Inc of New York, NY, are described in detail by chairman Steven Katz. The company develops epidermal and other biological products.

User Contributions:

Comment about this article or add new information about this topic:

Comment:  (50-4000 characters)

Name:

E-mail:

Security Code:

GeneLink, Inc. (GNLK)

Article Abstract:

The operations and management of GeneLink Inc of Margate, NJ, are discussed in detail by chairman and CEO John R. DePhillipo. The company is involved in human molecular genetics.

User Contributions:

Comment about this article or add new information about this topic:

Comment:  (50-4000 characters)

Name:

E-mail:

Security Code: